The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpectris Regulatory News (SXS)

Share Price Information for Spectris (SXS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,330.00
Bid: 3,324.00
Ask: 3,328.00
Change: 6.00 (0.18%)
Spread: 4.00 (0.12%)
Open: 3,308.00
High: 3,348.00
Low: 3,308.00
Prev. Close: 3,324.00
SXS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

25 May 2018 07:01

RNS Number : 2661P
Spectris PLC
25 May 2018
 

 

SPECTRIS PLC

DIRECTORATE CHANGE

25 May 2018 - The Board of Spectris plc (SXS: LSE), the productivity-enhancing instrumentation and controls company, announces that it has been informed by John O'Higgins of his intention to retire from the Board in the course of the next twelve months.

 

John will remain as Chief Executive until a replacement is in place and a formal process to recruit his successor, considering both internal and external candidates, will commence shortly.

 

Mark Williamson, Chairman, said: "John has had a very successful 12 years as Chief Executive of Spectris and on behalf of the Board I would like to thank him for his substantial contribution during his tenure. The Group has grown significantly in that time and he will be leaving a stronger company with a clear strategy already underway for the transformation into a leading supplier of solutions for our customers. The Board appreciates the significant value John has added to Spectris."

 

John O'Higgins, Chief Executive, said: "I have thoroughly enjoyed being part of Spectris' success story and am pleased that the Group is well placed to deliver on its growth strategy. I will leave behind a team of highly experienced people to continue to take Spectris forward and realise its strategic ambitions."

 

Mr. O'Higgins' departure terms will be consistent with Spectris' approved Directors Remuneration Policy. Details of any payments to be made to Mr. O'Higgins will be posted on the Company's website, in due course, in accordance with section 430(2B) Companies Act 2006.Mr. O'Higgins will continue to receive his normal remuneration whilst he remains an employee of Spectris.

- ENDS -

 

Contacts:

Spectris plc

John O'Higgins, Chief Executive

+44 1784 470470

Clive Watson, Group Finance Director

+44 1784 470470

Siobhán Andrews, Head of Corporate Affairs

+44 1784 485325

FTI Consulting

Richard Mountain / Susanne Yule

+44 203 727 1374

ABOUT SPECTRIS

Spectris plc is a leading supplier of productivity-enhancing instrumentation and controls. The Company's products, technologies and services help customers to improve product quality and performance, improve core manufacturing processes, reduce downtime and wastage and reduce time to market. Its global customer base spans a diverse range of end-user markets. Spectris operates across four business segments which reflect the applications and industries it serves: Materials Analysis, Test and Measurement, In-line Instrumentation and Industrial Controls. Headquartered in Egham, Surrey, United Kingdom, the Company employs approximately 9,800 people located in more than 30 countries. For more information, visit www.spectris.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAAIMMTMBTTTBP
Date   Source Headline
8th Dec 20222:21 pmRNSDirector/PDMR Shareholding
7th Dec 20225:32 pmRNSTransaction in Own Shares
6th Dec 20225:55 pmRNSTransaction in Own Shares
6th Dec 20227:00 amRNSTransaction in Own Shares
5th Dec 20227:00 amRNSTransaction in Own Shares
1st Dec 20225:59 pmRNSTransaction in Own Shares
1st Dec 202211:32 amRNSTotal Voting Rights
1st Dec 202211:18 amRNSVoting Rights and Capital
1st Dec 20227:00 amRNSTransaction in Own Shares
30th Nov 20227:00 amRNSTransaction in Own Shares
28th Nov 20226:23 pmRNSTransaction in Own Shares
25th Nov 20225:34 pmRNSTransaction in Own Shares
24th Nov 20226:31 pmRNSTransaction in Own Shares
24th Nov 20227:00 amRNSTransaction in Own Shares
22nd Nov 20225:51 pmRNSTransaction in Own Shares
22nd Nov 20221:58 pmRNSDirector/PDMR Shareholding
22nd Nov 20227:00 amRNSTransaction in Own Shares
21st Nov 20227:00 amRNSTransaction in Own Shares
18th Nov 20227:00 amRNSTransaction in Own Shares
17th Nov 20227:00 amRNSTransaction in Own Shares
16th Nov 20227:00 amRNSTransaction in Own Shares
15th Nov 202212:03 pmRNSDirector/PDMR Shareholding
15th Nov 20229:45 amRNSNotice of GM
15th Nov 20227:00 amRNSTransaction in Own Shares
11th Nov 20225:39 pmRNSTransaction in Own Shares
10th Nov 20226:20 pmRNSTransaction in Own Shares
10th Nov 20227:00 amRNSTransaction in Own Shares
9th Nov 20227:00 amRNSTransaction in Own Shares
8th Nov 20222:02 pmRNSDirector/PDMR Shareholding
8th Nov 20227:00 amRNSTransaction in Own Shares
7th Nov 20227:00 amRNSTransaction in Own Shares
3rd Nov 20225:56 pmRNSTransaction in Own Shares
3rd Nov 20227:00 amRNSTransaction in Own Shares
2nd Nov 20227:00 amRNSTransaction in Own Shares
1st Nov 20222:24 pmRNSTotal Voting Rights
1st Nov 20227:00 amRNSTransaction in Own Shares
31st Oct 20227:00 amRNSTransaction in Own Shares
28th Oct 20227:00 amRNSTransaction in Own Shares
27th Oct 20227:00 amRNSTransaction in Own Shares
25th Oct 20226:19 pmRNSTransaction in Own Shares
24th Oct 20225:51 pmRNSTransaction in Own Shares
21st Oct 20226:12 pmRNSTransaction in Own Shares
21st Oct 20227:00 amRNSTransaction in Own Shares
20th Oct 20227:00 amRNSTransaction in Own Shares
19th Oct 20227:00 amRNSQ3 trading update
19th Oct 20227:00 amRNSStrategy for Sustainable Growth and new targets
18th Oct 20226:02 pmRNSTransaction in Own Shares
18th Oct 20227:00 amRNSTransaction in Own Shares
17th Oct 20227:00 amRNSTransaction in Own Shares
14th Oct 20227:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.